Latest News

It may seem like a gaming company might be vulnerable to recessions, but this one should be just fine.

FCOJ closed much higher in response to the pause on tariff implementation made by the White House.

It’s still all about trade but there are a few other things to watch this week.

Stocks are firmly higher Monday, as a surprise tariff exemption from President Donald Trump sparked a rally in the tech sector.

President Trump signed an executive order aimed at reviving America’s coal industry. The order outlines an ambitious strategy to reclassify coal as a critical mineral and provide federal support for coal-fired electricity and coal exports.

CBOT corn ended sharply higher amid a further collapse in the U.S. dollar and the lack of retaliation from importers.

Unusual volume stocks are being observed in Monday's session.

The Canadian Dollar appears to have finally run out of steam.

Truist Securities analysts slashed price forecasts for JPMorgan and Wells Fargo following their first-quarter earnings release.

Oil prices rise on US-Iran diplomacy and trade war lull, boosting energy ETFs. Companies like ExxonMobil and Chevron benefit. OPEC lowers demand forecast.

Morgan Stanley's Q1 2025 results show a 17% revenue increase and higher EPS, surpassing market expectations despite credit loss provision rise.

A man, who pleaded guilty to hiding millions from the IRS, faces six years in prison since cryptocurrency reporting is mandatory.

Longevity announced it entered into a merger agreement with 20/20 BioLabs.

Shares of major automakers such as Ford Motors Inc. (NYSE: F), General Motos Inc. (NYSE: GM) and Stellantis Inc. (NYSE: STLA) are trading higher Monday after President Donald Trump indicated he wants to support car companies navigating recent trade changes.

Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Monday.

This comes after JPMorgan CEO Jamie Dimon’s remarks last week indicating that more analysts would trim their S&P 500 earnings estimates as the Trump tariff impact sinks in.

Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.

Valneva's chikungunya vaccine Ixchiq receives Brazil approval, enabling expanded trials and access across Latin America and endemic regions.

Ironwood must run a new Phase 3 trial after FDA talks, delaying its SBS drug approval despite strong results from prior studies.

Thirty-four percent of the respondents said they were bullish on the stock as a long-term investment, while 31% held a positive view as a short-term trade.

Certara reports $106M Q1 revenue, authorizes $100M buyback, and launches a new AI-driven non-animal testing tool to support biopharma innovation.